Analysts expect TherapeuticsMD, Inc. to report revenue of 522,175.00 for Q2 23, against a range of 485,027.99 to 559,322.01. The most recent reported quarter, Q2 26, came in at 869,000.00, a 63.2% miss against the 2.36 M consensus.
| Metric | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 400,000.00 | - | - | - | - | - | - | - | 393,000.00 | 952,000.00 | 784,000.00 | 893,000.00 | 724,000.00 | 869,000.00 | - | |||||||||
| High Estimate | 1.72 M | 559,322.01 | 558,009.18 | 591,099.67 | 2.21 M | 2.43 M | 2.28 M | 2.59 M | 2.74 M | 2.37 M | 2.21 M | 2.02 M | 3.14 M | 2.45 M | 2.21 M | |||||||||
| Low Estimate | 1.57 M | 485,027.99 | 503,620.82 | 535,406.33 | 2.03 M | 2.13 M | 2.04 M | 2.13 M | 2.41 M | 2.04 M | 1.94 M | 1.89 M | 2.80 M | 2.27 M | 1.99 M | |||||||||
| Consensus Estimate | 1.65 M | 522,175.00 | 530,815.00 | 563,253.00 | 2.12 M | 2.28 M | 2.16 M | 2.36 M | 2.57 M | 2.21 M | 2.07 M | 1.95 M | 2.97 M | 2.36 M | 2.10 M |
Analysts expect TherapeuticsMD, Inc. to report earnings per share of 0.04 for Q4 24, against a range of 0.04 to 0.04. The most recent reported quarter, Q2 26, came in at 0.01, a 33.9% beat against the 0.01 consensus.
| Metric | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.24 | -0.24 | -0.13 | -0.13 | -0.07 | -0.09 | -0.05 | - | -0.06 | 0.05 | 0.01 | -0.05 | 0.01 | 0.01 | - | - | - | - | - | - | - | |||
| High Estimate | 0.06 | -0.06 | -0.15 | -0.12 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.00 | 0.02 | 0.10 | 0.07 | 0.01 | 0.02 | 0.09 | 0.06 | 0.02 | 0.03 | 0.09 | 0.20 | |||
| Low Estimate | 0.06 | -0.08 | -0.17 | -0.14 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.00 | 0.02 | 0.08 | 0.05 | 0.01 | 0.02 | 0.07 | 0.06 | 0.02 | 0.03 | 0.07 | 0.16 | |||
| Consensus Estimate | 0.06 | -0.07 | -0.16 | -0.13 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.00 | 0.02 | 0.09 | 0.06 | 0.01 | 0.02 | 0.08 | 0.06 | 0.02 | 0.03 | 0.08 | 0.18 |
Pull Wall Street consensus for TherapeuticsMD, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=TXMD&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "TXMD", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=TXMD&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();